Gland Pharma Limited (NSE:GLAND)
India
· Delayed Price · Currency is INR 1,647.30
+13.70 (0.84%)
Jun 6, 2025, 11:30 AM IST
Gland Pharma Market Cap
Gland Pharma has a market cap or net worth of 269.15 billion as of June 5, 2025. Its market cap has decreased by -8.78% in one year.
Market Cap
269.15B
Enterprise Value
241.79B
Revenue
56.17B
Ranking
n/a
PE Ratio
38.53
Stock Price
1,647.30
Market Cap Chart
Since November 20, 2020, Gland Pharma's market cap has decreased from 297.10B to 269.15B, a decrease of -9.41%. That is a compound annual growth rate of -2.15%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 5, 2025 | 269.15B | -8.19% |
| Dec 31, 2024 | 293.15B | -7.51% |
| Dec 29, 2023 | 316.97B | 22.08% |
| Dec 30, 2022 | 259.64B | -59.11% |
| Dec 31, 2021 | 634.96B | 66.20% |
| Dec 31, 2020 | 382.04B | 28.59% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sun Pharmaceutical Industries | 4,000.89B |
| Divi's Laboratories | 1,733.51B |
| Cipla | 1,189.82B |
| Apollo Hospitals Enterprise | 994.34B |
| Mankind Pharma | 970.77B |
| Zydus Lifesciences | 932.18B |
| Aurobindo Pharma | 660.26B |
| Alkem Laboratories | 597.41B |